OraSure Technologies Inc
(NAS:OSUR)
$
4.32
0.07 (1.65%)
Market Cap: 319.50 Mil
Enterprise Value: 62.80 Mil
PE Ratio: 14.40
PB Ratio: 0.75
GF Score: 80/100 - Q1 2024 OraSure Technologies Inc Earnings Call TranscriptMay 08, 2024$5.31 (-4.15%)Earnings
- Q4 2023 OraSure Technologies Inc Earnings Call TranscriptFeb 27, 2024$7.03 (+0.29%)Earnings
- OraSure Technologies Inc to Discuss Its Strategic Relationship with Sapphiros Call TranscriptJan 04, 2024
- Q3 2023 OraSure Technologies Inc Earnings Call TranscriptNov 07, 2023$5.75 (+1.95%)Earnings
- Q2 2023 OraSure Technologies Inc Earnings Call TranscriptAug 03, 2023$4.49 (-0.44%)Earnings
- Q1 2023 OraSure Technologies Inc Earnings and Investor Day Call TranscriptMay 10, 2023
- Q4 2022 OraSure Technologies Inc Earnings Call TranscriptFeb 14, 2023$4.93 (-1.60%)Earnings
- Q3 2022 OraSure Technologies Inc Earnings Call TranscriptNov 08, 2022$4.26 (-2.74%)Earnings
- Q2 2022 OraSure Technologies Inc Earnings Call TranscriptAug 09, 2022$3.19 (-3.04%)Earnings
- Q1 2022 OraSure Technologies Inc Earnings Call TranscriptMay 10, 2022$5.27 (-6.56%)Earnings
- Q4 2021 OraSure Technologies Inc Earnings Call TranscriptFeb 23, 2022$7.51 (-4.45%)Earnings
- Q3 2021 OraSure Technologies Inc Earnings Call TranscriptNov 03, 2021$11.14 (+2.67%)Earnings
- Q2 2021 OraSure Technologies Inc Earnings Call TranscriptAug 03, 2021$12.41 (+4.81%)Earnings
- OraSure Technologies Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 23, 2021
- OraSure Technologies Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2021
- OraSure Technologies Inc at UBS Global Healthcare Virtual Conference TranscriptMay 26, 2021
- OraSure Technologies Inc Annual Shareholders Meeting TranscriptMay 18, 2021
- Q1 2021 OraSure Technologies Inc Earnings Call TranscriptMay 05, 2021$9.02 (-2.70%)Earnings
- Q4 2020 OraSure Technologies Inc Earnings Call TranscriptMar 01, 2021$11.06 (+4.34%)Earnings
- OraSure Technologies Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Q3 2020 OraSure Technologies Inc Earnings Call TranscriptNov 04, 2020$14.78 (-1.34%)Earnings
- Q2 2020 OraSure Technologies Inc Earnings Call TranscriptAug 05, 2020$19.58 (+1.50%)Earnings
- OraSure Technologies Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- OraSure Technologies Inc Annual Shareholders Meeting TranscriptMay 19, 2020
- Q1 2020 OraSure Technologies Inc Earnings Call TranscriptMay 06, 2020$16.26 (+5.17%)Earnings
- Q4 2019 OraSure Technologies Inc Earnings Call TranscriptFeb 19, 2020$7.12 (+8.37%)Earnings
- OraSure Technologies Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 OraSure Technologies Inc Earnings Call TranscriptNov 06, 2019$8.88 (-0.11%)Earnings
- Q2 2019 OraSure Technologies Inc Earnings Call TranscriptAug 06, 2019$7.83 (-1.39%)Earnings
- OraSure Technologies Inc at UBS Global Healthcare Conference TranscriptMay 22, 2019
- OraSure Technologies Inc Annual Shareholders Meeting TranscriptMay 21, 2019
- Q1 2019 OraSure Technologies Inc Earnings Call TranscriptMay 08, 2019$9.75Earnings
OraSure Technologies Inc at UBS Global Healthcare Conference Transcript
May 22, 2019 / 01:30PM GMT
Release Date Price:
$8.39
(-0.94%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
So listen, welcome. Day 3 UBS Global Healthcare Conference. Pleased to be joined on stage -- with me is the senior management team of OraSure. My name is Dan Brennan. I cover tools, diagnostics and pharma services. Before we start, I'll direct you to the UBS website at www.ubs.com for all the relevant analyst disclaimer information. So with me to my left is Steve Tang, President and CEO. And to his left is Roberto, and I apologize...
Roberto E. Cuca
OraSure Technologies, Inc. - CFO & Principal Accounting Officer
Cuca.
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Cuca. I wanted to make sure I had that correct -- who's the Chief Financial Officer. I think Steve's going to go through a series of slides. And then afterwards, we'll have a fireside with a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)